These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
Smoking is responsible for 80% to 90% of chronic obstructive pulmonary disease (copd) cases, including emphysema.
Chronic obstructive pulmonary disease (COPD) in a patient can be treated by administering to said patient an effective dose of an extract of Petasites sp.
Smoking is responsible for 80% to 90% of chronic obstructive pulmonary disease (COPD) cases, including emphysema.
This invention finds utility in the treatment and prevention of asthma, COPD, pulmonary fibrosis, emphysema, and other pulmonary diseases.
The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.
The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.
The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.
The formulation can be used to treat or prevent asthma, chronic obstructive pulmonary disease, lung inflammation, and other respiratory diseases or conditions.
The subjects are chronic obstructive pulmonary disease (COPD) patients.
It is intended to provide diagnostics for bronchial asthma or chronic obstructive pulmonary disease.
The invention relates to the use of a combination of cannabinoids for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
6 percent of the population suffer from COPD (Chronic Obstructive Pulmonary Disease).
Chronic obstructive pulmonary disease and allied conditions (490-496)
Such disorders include rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease).
Lung disease patients comprise chronic obstructive lung disease (COPD) patients.
Chronic obstructive pulmonary diseases and allied conditions (490-496)
Chronic obstructive pulmonary disease phenotypes: implications for care.
Phenotyping of chronic obstructive pulmonary disease: heterogeneity and its clinical relevance.
Chronic obstructive pulmonary disease and allied conditions (490-496)
17 November – World Chronic Obstructive Pulmonary Disease Day (WHO)
Chronic obstructive pulmonary disease phenotypes: Implications for Care.
A method for diagnosing and staging of chronic obstructive pulmonary disease (COPD) includes measuring expression of one or more miRNAs levels in a subject suspected of suffering from COPD.
Treatment and diagnostic methods are provided for pulmonary disease, including chronic obstructive pulmonary disease.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод